Latest filing published 30 Dec 2022 for Advanced Oncotherapy plc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Bradfield: trading record in brief
This profile gathers the share dealings of Michael Bradfield in Advanced Oncotherapy plc. Between 3 February 2015 and 29 December 2022, the trades on record add up to 5 filings.
The open-market record is one-sided, with 5 purchases worth €338k and not one sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 1 purchase and no sales on the market.
The median purchase comes to €55k.
The latest filing, published on 30 December 2022, reports an open-market purchase in Advanced Oncotherapy plc. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Bradfield
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500,000 sharesLondon Stock ExchangeISIN GB00BD6SX109FCA-NSM:4628674Canonical exit: 29 Mar 2023 (T+90)
- 1,500,000 shares@ £0.0981FCA-NSM:LSE20150608070013_012380156_20200330172147047Canonical exit: 1 Sept 2015 (T+90)
- 1,500,000 shares@ £0.042FCA-NSM:LSE20150205070024_012239259_20200330172135956Canonical exit: 5 May 2015 (T+90)
- 500,000 shares@ £0.041FCA-NSM:LSE20150204085255_012238014_20200330172135925Canonical exit: 4 May 2015 (T+90)
- 500,000 shares@ £0.041FCA-NSM:LSE20150204070020_012237701_20200330172135914Canonical exit: 5 May 2015 (T+90)
5 of 5 declarations